TITLE

Pluristem, United Therapeutics Sign $62M Licensing Deal

PUB. DATE
June 2011
SOURCE
Bioworld Week;6/27/2011, Vol. 19 Issue 26, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the licensing deal signed by Pluristem Ltd. with United Therapeutics Corp. for its PLacental eXpanded (PLX) cell pipeline in the U.S.
ACCESSION #
62970915

 

Related Articles

  • Pluristem, United Therapeutics Sign $62M Licensing Deal. Serebrov, Mari // BioWorld Today;6/21/2011, Vol. 22 Issue 119, p1 

    The article reports on a licensing agreement worth 62 million dollars signed between Pluristem Ltd. and United Therapeutics Corp. The agreement will finance Pluristem's PLacental eXpanded (PLX) cell pipeline. Pluristem will also receive 7 million dollars in up front and 55 million dollars in...

  • United Kills Cancer Program Following Pivotal Trial Failures.  // BioWorld Today;12/6/2007, Vol. 18 Issue 236, p2 

    The article reveals the decision of United Therapeutics Corp. (UTC) to cease development of its OvaRex ovarian cancer candidate following the failure of two pivotal trials. The studies examined the efficacy of OvaRex monoimmunotherapy during the watchful waiting period. UTC also noted Unither...

  • Art of Spec Pharm Licensing: Balancing Risk & Innovation. Orelli, Brian // BioWorld Insight;6/27/2011, Vol. 19 Issue 26, p2 

    The article focuses on the approaches and strategies of specialty pharmaceutical companies toward licensing and acquisition deals across drug innovation. It states that the drug Oxectra from, in-licenced from Acura Pharmaceuticals Inc. by Pfizer Inc. was approved. It says that Placental eXpanded...

  • Other News To Note.  // BioWorld Today;9/21/2012, Vol. 23 Issue 184, p5 

    This section offers news briefs on the biopharmaceutical sector. A regulatory meeting was conducted by Biovest International Inc. with the European Medicines Agency about its personalized cancer vaccine BiovaxID for non-Hodgkin's lymphoma. A strategic licensing agreement was signed between Dyax...

  • Europe's license law.  // Chemical Week;8/2/1995, Vol. 157 Issue 4, p33 

    Reports on the European Commission's renewal of two laws on technology licensing arrangements until the end of 1995.

  • LMDS explosion. Levine, Shira // Telephony;3/17/97, Vol. 232 Issue 11, p6 

    Discusses the limitation of obtaining licenses of the local exchange carriers (LECs) for the LMDS spectrum. Activation of cable as non-video competitor and telephony as video competitor; Contradiction of the order to the intents of Telecommunications Reform Act; Analysis on the amortization of...

  • Hingassa to represent surface combustion.  // Industrial Heating;Dec96, Vol. 63 Issue 12, p35 

    Focuses on the product and technology license agreement between Surface Combustion and Hingassa Hornos Ingenieria Gas SA of Spain. Hingassa's representation of Surface in Spain and in Portugal; Terms of the agreement.

  • PCS auctions resume with plenty more to come. Wayne, Debra // RCR;01/13/97, Vol. 16 Issue 2, p4 

    Focuses on the restart of the personal communications services (PCS) license auction in 1997. Which blocks are involved in the auction; Information on bidding activity; Statements from PCS analyst, Taylor Simmons; Top 10 bidders by total dollars.

  • Brands, and licenses of longevity. Siegel, Seth M. // Brandweek;9/11/95, Vol. 36 Issue 34, p21 

    Opinion. Comments on the illogicality behind product licensing agreements. Adoption of brand name product's credo of longevity; Licensor's negotiation of two-year initial term; Control of product innovation and advertising budget.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics